Le Moing V - Search Results

1

Response to highly active antiretroviral therapy at 6 months and long-term disease progression in HIV-1 infection.

Grabar S, Le Moing V, Goujard C, Egger M, Leport C, Kazatchkine MD, Weiss L, Costagliola D. Grabar S, et al. Among authors: le moing v. J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):284-92. doi: 10.1097/01.qai.0000160925.33935.72. J Acquir Immune Defic Syndr. 2005. PMID: 15980687

2

[Infectious complications of cardiac valve prostheses].

Le Moing V, Leport C. Le Moing V, et al. Rev Med Interne. 1997;18 Suppl 5:427s-430s. doi: 10.1016/s0248-8663(97)80149-x. Rev Med Interne. 1997. PMID: 9515156 Review. French. No abstract available.

3

Decreased prevalence of intestinal cryptosporidiosis in HIV-infected patients concomitant to the widespread use of protease inhibitors.

Le Moing V, Bissuel F, Costagliola D, Eid Z, Chapuis F, Molina JM, Salmon-Ceron D, Brasseur P, Leport C. Le Moing V, et al. AIDS. 1998 Jul 30;12(11):1395-7. doi: 10.1097/00002030-199811000-00026. AIDS. 1998. PMID: 9708424 No abstract available.

4

[Infections and lupus].

Le Moing V, Leport C. Le Moing V, et al. Rev Prat. 1998 Mar 15;48(6):637-42. Rev Prat. 1998. PMID: 9781135 Review. French.

5

Use of corticosteroids in glomerulonephritis related to infective endocarditis: three cases and review.

Le Moing V, Lacassin F, Delahousse M, Duval X, Longuet P, Leport C, Vildé JL. Le Moing V, et al. Clin Infect Dis. 1999 May;28(5):1057-61. doi: 10.1086/514734. Clin Infect Dis. 1999. PMID: 10452634 Review.

6

Two episodes of acute renal failure, rhabdomyolysis, and severe hepatitis in an AIDS patient successively treated with ritonavir and indinavir.

Benveniste O, Longuet P, Duval X, Le Moing V, Leport C, Vildé JL. Benveniste O, et al. Among authors: le moing v. Clin Infect Dis. 1999 May;28(5):1180-1. doi: 10.1086/517777. Clin Infect Dis. 1999. PMID: 10452668 No abstract available.

7

Definition of virologic response and the type of assay used for quantification of viral load may influence the proportion of responders to antiretroviral therapy. APROCO Study Group.

Le Moing V, Chêne G, Masquelier B, Sicard D, Brun-Vézinet F, Reynes J, Raffi F. Le Moing V, et al. J Acquir Immune Defic Syndr. 2000 May 1;24(1):82-3. doi: 10.1097/00126334-200005010-00016. J Acquir Immune Defic Syndr. 2000. PMID: 10877502 No abstract available.

8

Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy.

Grabar S, Le Moing V, Goujard C, Leport C, Kazatchkine MD, Costagliola D, Weiss L. Grabar S, et al. Among authors: le moing v. Ann Intern Med. 2000 Sep 19;133(6):401-10. doi: 10.7326/0003-4819-133-6-200009190-00007. Ann Intern Med. 2000. PMID: 10975957

9

Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients. The APROCO Study Group.

Savès M, Raffi F, Clevenbergh P, Marchou B, Waldner-Combernoux A, Morlat P, Le Moing V, Rivière C, Chêne G, Leport C. Savès M, et al. Among authors: le moing v. Antimicrob Agents Chemother. 2000 Dec;44(12):3451-5. doi: 10.1128/AAC.44.12.3451-3455.2000. Antimicrob Agents Chemother. 2000. PMID: 11083658 Free PMC article.

10

[Long-term immunologic response in HIV-infected patients with CD4 cell counts </= 50/mm3 when initiating protease inhibitor therapy].

Le Moing V, Eid Z, Ecobichon JL, Duval X, Longuet P, Elbim C, Brun-Vezinet F, Leport C, Vilde JL. Le Moing V, et al. Ann Med Interne (Paris). 2001 Feb;152(1):11-4. Ann Med Interne (Paris). 2001. PMID: 11240420 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

281 results

Search Page